Advertisement
Person › Details
Eric Halioua (PDC*line Pharma S.A. (BE))
Halioua, Eric (PDC*line Pharma 201612– CEO before Promethera 200906– CEO)
Organisation | PDC*line Pharma S.A. (BE) | |
Group | PDC*line Pharma (Group) | |
Former/major organisation | Promethera Biosciences S.A. | |
Today | Promethera Therapeutics S.A. | |
Group | Promethera (Group) | |
Record changed: 2022-04-24 |
Advertisement
More documents for Eric Halioua
- [1] PDC*line Pharma S.A.. (3/2/20). "Press Release: PDC*line Pharma Announces the Administration of a First Patient with Its Therapeutic Cancer Vaccine Candidate (PDC*lung01) Targeting Non-small Cell Lung Cancer". Liège & Grenoble....
- [2] PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top